Hepatobiliary malignancy represents a challenging group of diseases with limited treatment options. Conventional therapies for hepatobiliary cancer include surgical resection, liver transplantation, chemotherapy, and radiation therapy. However, these approaches often face limitations due to the advanced nature of the disease and the heterogeneous t